Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...

The US Food and Drug Administration has approved Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.

Sept 27 (Reuters) - Pregnant women who do not get enough sleep may be at higher risk of having children with ...

U.S. equities were mixed at midday as the Federal Reserve's favored measure of inflation was lower than anticipated.

U.S. stock indexes are drifting around their records as hopes hold that the economy can pull off the feat of getting ...

Bristol Myers Squibb (BMY) is up more than +1% after gaining FDA approval for its Cobenfy drug to treat patients with schizophrenia. Amgen (AMGN) is up more than +1% after Cantor Fitzgerald initiated ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of stock of Metagenomi, Inc. pursuant and/or traceable to the Company's ...

The Dow Jones Industrial Average hit an intraday record as small-cap stocks outperformed following a positive inflation ...

London stocks closed higher on Friday as investors digested a slowdown in the Federal Reserve’s preferred inflation measure.

ABC News' Linsey Davis speaks with White House National Security spokesman John Kirby on the latest in the cease-fire negotiations between Lebanon and Israel as tensions escalate in the region.